143 related articles for article (PubMed ID: 37823879)
21. Liquid biopsy: a new diagnostic, predictive and prognostic window in cancers of unknown primary.
El Rassy E; Khaled H; Pavlidis N
Eur J Cancer; 2018 Dec; 105():28-32. PubMed ID: 30388661
[TBL] [Abstract][Full Text] [Related]
22. [Cancer of unknown primary site origin--advances in diagnosis and therapy].
Plot L; Dovrish Z; Hadari R; Weisenberg N; Zehavi T; Nisenbaum B; Amital H
Harefuah; 2008 Apr; 147(4):294-8, 376, 375. PubMed ID: 18686808
[TBL] [Abstract][Full Text] [Related]
23. Cancer of unknown primary site: 20 questions to be answered.
Pavlidis N; Pentheroudakis G
Ann Oncol; 2010 Oct; 21 Suppl 7():vii303-7. PubMed ID: 20943633
[TBL] [Abstract][Full Text] [Related]
24. AI-based pathology predicts origins for cancers of unknown primary.
Lu MY; Chen TY; Williamson DFK; Zhao M; Shady M; Lipkova J; Mahmood F
Nature; 2021 Jun; 594(7861):106-110. PubMed ID: 33953404
[TBL] [Abstract][Full Text] [Related]
25. [Favourable course of cancer of unknown primary].
van de Wouw AJ; van Marion AMW; Jansen RLH
Ned Tijdschr Geneeskd; 2019 May; 163():. PubMed ID: 31141323
[TBL] [Abstract][Full Text] [Related]
26. The role of molecular profiling in the diagnosis and management of metastatic undifferentiated cancer of unknown primary
Dermawan JK; Rubin BP
Semin Diagn Pathol; 2021 Nov; 38(6):193-198. PubMed ID: 33309276
[TBL] [Abstract][Full Text] [Related]
27. Unknown primary carcinoma in the Netherlands: decrease in incidence and survival times remain poor between 2000 and 2012.
Schroten-Loef C; Verhoeven RHA; de Hingh IHJT; van de Wouw AJ; van Laarhoven HWM; Lemmens VEPP
Eur J Cancer; 2018 Sep; 101():77-86. PubMed ID: 30031970
[TBL] [Abstract][Full Text] [Related]
28. Cancers of unknown primary origin (CUP) are characterized by chromosomal instability (CIN) compared to metastasis of know origin.
Vikeså J; Møller AK; Kaczkowski B; Borup R; Winther O; Henao R; Krogh A; Perell K; Jensen F; Daugaard G; Nielsen FC
BMC Cancer; 2015 Mar; 15():151. PubMed ID: 25885340
[TBL] [Abstract][Full Text] [Related]
29. Machine learning-based tissue of origin classification for cancer of unknown primary diagnostics using genome-wide mutation features.
Nguyen L; Van Hoeck A; Cuppen E
Nat Commun; 2022 Jul; 13(1):4013. PubMed ID: 35817764
[TBL] [Abstract][Full Text] [Related]
30. Long-term survivors among patients with cancer of unknown primary.
Pavlidis N; Petrakis D; Golfinopoulos V; Pentheroudakis G
Crit Rev Oncol Hematol; 2012 Oct; 84(1):85-92. PubMed ID: 22386806
[TBL] [Abstract][Full Text] [Related]
31. An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin.
Tothill RW; Kowalczyk A; Rischin D; Bousioutas A; Haviv I; van Laar RK; Waring PM; Zalcberg J; Ward R; Biankin AV; Sutherland RL; Henshall SM; Fong K; Pollack JR; Bowtell DD; Holloway AJ
Cancer Res; 2005 May; 65(10):4031-40. PubMed ID: 15899792
[TBL] [Abstract][Full Text] [Related]
32. Study protocol of the GLOW study: maximising treatment options for recurrent glioblastoma patients by whole genome sequencing-based diagnostics-a prospective multicenter cohort study.
van Opijnen MP; Broekman MLD; de Vos FYF; Cuppen E; van der Hoeven JJM; van Linde ME; Compter A; Beerepoot LV; van den Bent MJ; Vos MJ; Fiebrich HB; Koekkoek JAF; Hoeben A; Kho KH; Driessen CML; Jeltema HR; Robe PAJT; Maas SLN
BMC Med Genomics; 2022 Nov; 15(1):233. PubMed ID: 36333718
[TBL] [Abstract][Full Text] [Related]
33. Genetic characterisation of molecular targets in carcinoma of unknown primary.
Clynick B; Dessauvagie B; Sterrett G; Harvey NT; Allcock RJN; Saunders C; Erber W; Meehan K
J Transl Med; 2018 Jul; 16(1):185. PubMed ID: 29973234
[TBL] [Abstract][Full Text] [Related]
34. Extensive diagnostic work-up for patients with carcinoma of unknown primary.
Meijer L; Verhoeven RHA; de Hingh IHJT; van de Wouw AJ; van Laarhoven HWM; Lemmens VEPP; Loef C
Clin Exp Metastasis; 2021 Apr; 38(2):231-238. PubMed ID: 33515369
[TBL] [Abstract][Full Text] [Related]
35. Cancers of unknown primary origin: current perspectives and future therapeutic strategies.
Stella GM; Senetta R; Cassenti A; Ronco M; Cassoni P
J Transl Med; 2012 Jan; 10():12. PubMed ID: 22272606
[TBL] [Abstract][Full Text] [Related]
36. [Pathological diagnostics of CUP (Cancer of Unknown Primary)].
Tímár J
Magy Onkol; 2019 Jun; 63(2):67-74. PubMed ID: 31225529
[TBL] [Abstract][Full Text] [Related]
37. Assessing the utility of molecular diagnostic classification for cancers of unknown primary.
Moore EC; Blobe GC; DeVito NC; Hanks BA; Harrison MR; Hoimes CJ; Jia J; Morse MA; Jayaprakasan P; MacKelfresh A; Mulder H; Hockenberry AJ; Zander A; Stumpe MC; Michuda J; Beauchamp KA; Perakslis E; Taxter T; George DJ
Cancer Med; 2023 Oct; 12(19):19394-19405. PubMed ID: 37712677
[TBL] [Abstract][Full Text] [Related]
38. A molecular approach integrating genomic and DNA methylation profiling for tissue of origin identification in lung-specific cancer of unknown primary.
Chen K; Zhang F; Yu X; Huang Z; Gong L; Xu Y; Li H; Yu S; Fan Y
J Transl Med; 2022 Apr; 20(1):158. PubMed ID: 35382836
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA expression profiling with a droplet digital PCR assay enables molecular diagnosis and prognosis of cancers of unknown primary.
Laprovitera N; Riefolo M; Porcellini E; Durante G; Garajova I; Vasuri F; Aigelsreiter A; Dandachi N; Benvenuto G; Agostinis F; Sabbioni S; Berindan Neagoe I; Romualdi C; Ardizzoni A; Trerè D; Pichler M; D'Errico A; Ferracin M
Mol Oncol; 2021 Oct; 15(10):2732-2751. PubMed ID: 34075699
[TBL] [Abstract][Full Text] [Related]
40. Identification of tissue of origin in carcinoma of unknown primary with a microarray-based gene expression test.
Monzon FA; Medeiros F; Lyons-Weiler M; Henner WD
Diagn Pathol; 2010 Jan; 5():3. PubMed ID: 20205775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
